Articles

Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B

Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA
Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA
Integrative Genomics and Bioinformatics Core, Salk Institute for Biological Studies, La Jolla, CA, USA
Center for Computational Biology, Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA;CLL Research Consortium, and Department of Medicine, University of California, San Diego, La Jolla, CA, USA
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA;CLL Research Consortium, and Department of Medicine, University of California, San Diego, La Jolla, CA, USA
Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA;CLL Research Consortium, and Department of Medicine, University of California, San Diego, La Jolla, CA, USA
Vol. 100 No. 7 (2015): July, 2015 https://doi.org/10.3324/haematol.2014.122069